Works matching DE "TENOFOVIR"

Results: 1852

Weight loss with real-world doravirine use in the OPERA cohort: a US-based cohort study.

Published in:

AIDS Research & Therapy, 2025, v. 22, n. 1, p. 1, doi. 10.1186/s12981-025-00761-5

By:

Mounzer, Karam;
Brunet, Laurence;
Sension, Michael;
Hsu, Ricky K.;
Osterman, Michael D.;
Fusco, Jennifer S.;
Whiteside, Yohance O.;
Fusco, Gregory P.

Publication type:

Article

Aseptic osteonecrosis of the jaw in a patient with HIV on tenofovir.

Published in:

Baylor University Medical Center Proceedings, 2025, v. 38, n. 4, p. 561, doi. 10.1080/08998280.2025.2457077

By:

Bhattarai, Shraddha;
Bhattarai, Shashank;
Dondapati, Lavanya;
Macapinlac, Eric;
Kolade, Victor

Publication type:

Article

Effect of weight gain on blood pressure in Ugandan persons with HIV on dolutegravir/lamivudine/ tenofovir disoproxil fumarate over 48 weeks.

Published in:

PLoS ONE, 2025, v. 20, n. 6, p. 1, doi. 10.1371/journal.pone.0325020

By:

Amutuhaire, Willington;
Castelnuovo, Barbara;
Brusselaers, Nele;
Nabwana, Martin;
Muhammad, Lal;
Maloney, Brendan;
Nixon, Bridgette;
Schwarz, Jean-Marc;
Mulindwa, Frank

Publication type:

Article

Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) After A Viremic Event: A Pooled Analysis of Studies in People with HIV.

Published in:

Infectious Diseases & Therapy, 2025, v. 14, n. 6, p. 1201, doi. 10.1007/s40121-025-01153-y

By:

Pozniak, Anton;
Orkin, Chloe;
Yazdanpanah, Yazdan;
Baumgarten, Axel;
Mounzer, Karam;
D'Antoni, Michelle L.;
Huang, Hailin;
Liu, Hui;
Andreatta, Kristen;
VanderVeen, Laurie A.;
Callebaut, Christian;
Hindman, Jason T.;
Arribas, José R.

Publication type:

Article

HBV Relapse after Discontiniuation of Tenofovir Alafenamide or Entecavir in Non-Cirrhotic Hepatitis B e Antigen-Negative Patients.

Published in:

Digestive Diseases, 2025, v. 43, n. 3, p. 336, doi. 10.1159/000544870

By:

Huang, Yi-Jie;
Lee, Shou-Wu;
Tung, Chun-Fang;
Liao, Szu-Chia;
Lee, Teng-Yu;
Peng, Yen-Chun;
Chang, Chung-Hsin;
Wang, Jun-Sing

Publication type:

Article

Why Tenofovir/Dolutegravir/Lamivudine if We Might Use Dolutegravir/Lamivudine.

Published in:

2025

By:

Buzón-Martín, Luis;
Troya, Jesús

Publication type:

Letter to the Editor

De novo Hepatitis B Virus Infection in a Post-transplant Patient Causing Stage 4 Cirrhosis Necessitating Retransplant.

Published in:

ACG Case Reports Journal, 2025, v. 12, n. 5, p. 1, doi. 10.14309/crj.0000000000001704

By:

Josloff, Kevan;
Young, Benjamin;
Hersh, Marc;
Bheemreddy, Alekya;
Lee, Sherry;
Halegoua-Demarzio, Dina

Publication type:

Article

Rethinking HIV treatment: How non‐integrase strand regimens may hold the key to better immune health.

Published in:

HIV Medicine, 2025, v. 26, n. 6, p. 879, doi. 10.1111/hiv.70020

By:

Aksak‐Wąs, Bogusz;
Skonieczna‐Żydecka, Karolina;
Parczewski, Miłosz;
Hrynkiewicz, Rafał;
Lewandowski, Filip;
Serwin, Karol;
Mielczak, Kaja;
Lenkiewicz, Franciszek;
Niedźwiedzka‐Rystwej, Paulina

Publication type:

Article

Assessing weight change in adolescents and young adults with perinatally acquired HIV and integrase inhibitor use.

Published in:

HIV Medicine, 2025, v. 26, n. 6, p. 870, doi. 10.1111/hiv.70019

By:

Pincus, Kathleen J.;
Faridi, Nabila;
Ryscavage, Patrick Amadeus;
Seung, Hyunuk;
Parbuoni, Kristine A.;
Grant, Matthew;
Pandit, Neha Sheth

Publication type:

Article

Efficacy and safety of bictegravir/emtricitabine/tenofovir alafenamide in Black and Hispanic/Latine adults with HIV‐1 initiating first‐line therapy: 5‐year follow‐up from two phase III studies.

Published in:

HIV Medicine, 2025, v. 26, n. 6, p. 858, doi. 10.1111/hiv.70018

By:

Martorell, C.;
Ramgopal, M.;
Hagins, D.;
Osiyemi, O.;
Arribas, J. R.;
Berhe, M.;
Yazdanpanah, Y.;
Orkin, C.;
Santiago, L.;
Rosero, C.;
Unger, N.;
Liu, H.;
Rogers, R.;
Hindman, J. T.;
Wurapa, A.

Publication type:

Article

In the news.

Published in:: Nature Reviews Microbiology, 2011, v. 9, n. 12, p. 837, doi. 10.1038/nrmicro2702
Publication type:: Article

Scaling Up the 2010 World Health Organization HIV Treatment Guidelines in Resource-Limited Settings: A Model-Based Analysis.

Published in:

PLoS Medicine, 2010, v. 7, n. 12, p. 1, doi. 10.1371/journal.pmed.1000382

By:

Walensky, Rochelle P.;
Wood, Robin;
Ciaranello, Andrea L.;
Paltiel, A. David;
Lorenzana, Sarah B.;
Anglaret, Xavier;
Stoler, Adam W.;
Freedberg, Kenneth A.

Publication type:

Article

Multivalent Tryptophan‐ and Tyrosine‐Containing [60]Fullerene Hexa‐Adducts as Dual HIV and Enterovirus A71 Entry Inhibitors.

Published in:

Chemistry - A European Journal, 2021, v. 27, n. 41, p. 10700, doi. 10.1002/chem.202101098

By:

Ruiz‐Santaquiteria, Marta;
Illescas, Beatriz M.;
Abdelnabi, Rana;
Boonen, Arnaud;
Mills, Alberto;
Martí‐Marí, Olaia;
Noppen, Sam;
Neyts, Johan;
Schols, Dominique;
Gago, Federico;
San‐Félix, Ana;
Camarasa, María‐José;
Martín, Nazario

Publication type:

Article

A medicinal chemist who reshaped the antiviral drug industry: John Charles Martin (1951–2021).

Published in:

Medicinal Research Reviews, 2022, v. 42, n. 2, p. 647, doi. 10.1002/med.21858

By:

Li, Guangdi;
De Clercq, Erik

Publication type:

Article

Longitudinal change in bone mineral density among Chinese individuals with HIV after initiation of antiretroviral therapy.

Published in:

Osteoporosis International, 2021, v. 32, n. 2, p. 321, doi. 10.1007/s00198-020-05584-w

By:

Guo, F.;
Song, X.;
Li, Y.;
Guan, W.;
Pan, W.;
Yu, W.;
Li, T.;
Hsieh, E.

Publication type:

Article

Reply to "Antiretroviral therapy options in people living with HIV at risk of or with osteoporosis. Comment on: Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis" by S. Noe, H. Jaeger, E. Wolf

Published in:

Osteoporosis International, 2019, v. 30, n. 8, p. 1707, doi. 10.1007/s00198-019-05025-3

By:

Biver, E.;
Calmy, A.;
Meier, C.

Publication type:

Article

Antiretroviral therapy options in people living with HIV at risk of or with osteoporosis: Comment on "Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis".

Published in:

Osteoporosis International, 2019, v. 30, n. 8, p. 1705, doi. 10.1007/s00198-019-05024-4

By:

Noe, S.;
Jaeger, H.;
Wolf, E.

Publication type:

Article

Factors associated with fractures in HIV-infected persons: which factors matter?

Published in:

Osteoporosis International, 2017, v. 28, n. 1, p. 239, doi. 10.1007/s00198-016-3704-6

By:

Gedmintas, L.;
Wright, E.;
Dong, Y.;
Lehmann, E.;
Katz, J.;
Solomon, D.;
Losina, E.

Publication type:

Article

Repositioning HIV protease inhibitors and nucleos(t)ide RNA polymerase inhibitors for the treatment of SARS-CoV-2 infection and COVID-19.

Published in:

European Journal of Clinical Pharmacology, 2021, v. 77, n. 9, p. 1297, doi. 10.1007/s00228-021-03108-x

By:

von Hentig, Nils

Publication type:

Article

Effects of guggulsterones-containing thermogenic complex on elvitegravir plasma concentrations: a case report.

Published in:

2019

By:

Cattaneo, Dario;
Ridolfo, Annalisa;
Baldelli, Sara;
Gervasoni, Cristina

Publication type:

Case Study

Adverse reactions associated with first-line regimens in patient initiating antiretroviral therapy.

Published in:

European Journal of Clinical Pharmacology, 2018, v. 74, n. 8, p. 1077, doi. 10.1007/s00228-018-2472-y

By:

Mendes, Jullye Campos;
Bonolo, Palmira de Fátima;
Ceccato, Maria das Graças Braga;
Costa, Juliana de Oliveira;
Reis, Adriano Max Moreira;
dos Santos, Henrique;
Silveira, Micheline Rosa

Publication type:

Article

The impact of gastrectomy on the pharmacokinetics of atazanavir and tenofovir.

Published in:

2017

By:

Gervasoni, Cristina;
Cattaneo, Dario;
Resnati, Chiara;
Pezzani, Diletta;
Riva, Agostino

Publication type:

Letter

Tenofovir-induced nephrotoxicity: incidence, mechanism, risk factors, prognosis and proposed agents for prevention.

Published in:

European Journal of Clinical Pharmacology, 2014, v. 70, n. 9, p. 1029, doi. 10.1007/s00228-014-1712-z

By:

Jafari, Atefeh;
Khalili, Hossein;
Dashti-Khavidaki, Simin

Publication type:

Article

The Different Prognoses of Hepatocellular Carcinoma with Previous Tenofovir versus Entecavir Treatment for Chronic Hepatitis B Virus: Analysis Based on 15 Propensity Score-Matched Studies.

Published in:

Digestive Diseases, 2023, v. 41, n. 3, p. 476, doi. 10.1159/000528711

By:

Hou, Jiancun;
Qiang, Zhe;
Li, Yang;
Zhang, Yamin

Publication type:

Article

Overcoming structural barriers to diffusion of HIV pre-exposure prophylaxis.

Published in:

Medicine Access @ Point of Care, 2023, v. 7, p. 1, doi. 10.1177/27550834231214958

By:

Magnus, Manya;
Yellin, Hannah;
Langlands, Kayley;
Balachandran, Madhu;
Turner, Melissa;
Jordan, Jeanne;
Ramin, Daniel;
Kuo, Irene;
Siegel, Marc

Publication type:

Article

Association between tenofovir plasma trough concentrations in the early stage of administration and discontinuation of up to five years tenofovir disoproxil fumarate due to renal function-related adverse events in Japanese HIV-1 infected patients.

Published in:

Journal of Pharmaceutical Health Care & Sciences, 2024, v. 10, n. 1, p. 1, doi. 10.1186/s40780-024-00343-z

By:

Yagura, Hiroki;
Watanabe, Dai;
Nakauchi, Takao;
Kushida, Hiroyuki;
Hirota, Kazuyuki;
Nishida, Yasuharu;
Yoshino, Munehiro;
Uehira, Tomoko;
Shirasaka, Takuma

Publication type:

Article

Renal function and lipid metabolism in Japanese HIV-1-positive individuals 288 weeks after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate: a single-center, retrospective cohort study.

Published in:

Journal of Pharmaceutical Health Care & Sciences, 2024, v. 10, n. 1, p. 1, doi. 10.1186/s40780-024-00336-y

By:

Abe, Kensuke;
Imamura, Junji;
Sasaki, Akiko;
Suzuki, Tomoko;
Kamio, Satomi;
Obara, Taku;
Ito, Toshihiro

Publication type:

Article

Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV‐infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabine.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2019, v. 124, n. 4, p. 479, doi. 10.1111/bcpt.13161

By:

Cid‐Silva, Purificación;
Fernández‐Bargiela, Noelia;
Margusino‐Framiñán, Luis;
Balboa‐Barreiro, Vanesa;
Mena‐De‐Cea, Álvaro;
López‐Calvo, Soledad;
Vázquez‐Rodríguez, Pilar;
Martín‐Herranz, Isabel;
Míguez‐Rey, Enrique;
Poveda, Eva;
Castro‐Iglesias, Ángeles

Publication type:

Article

Drugs for Infectious Disease.

Published in:: Basic & Clinical Pharmacology & Toxicology, 2014, v. 115, p. 223, doi. 10.1111/bcpt.12259_6
Publication type:: Article

Impact on L-carnitine Homeostasis of Short-term Treatment with the Pivalate Prodrug Tenofovir Dipivoxil.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2013, v. 113, n. 6, p. 431, doi. 10.1111/bcpt.12112

By:

Jia, Yan‐Yan;
Lu, Cheng‐Tao;
Feng, Juan;
Song, Ying;
Zhao, Jin‐Yi;
Wang, Shan;
Sun, Yuan;
Wen, Ai‐Dong;
Yang, Zhi‐Fu;
Hang, Tai‐Jun

Publication type:

Article

Temporal Changes in Renal Glomerular Function Associated with the use of Tenofovir Disoproxil Fumarate in HIV-Infected Nigerians.

Published in:

West African Journal of Medicine, 2011, v. 30, n. 3, p. 164

By:

Agbaji, O. O.;
Agaba, P. A.;
Idoko, J. A.;
Taiwo, B.;
Murphy, R.;
Kanki, P.;
Ekong, E.

Publication type:

Article

Tenofovir substitution in Namibia based on an analysis of the antiretroviral dispensing database.

Published in:

Journal of Pharmaceutical Policy & Practice, 2015, v. 8, p. 1, doi. 10.1186/s40545-015-0034-6

By:

Kalemeera, Francis;
Mengistu, Assegid T.;
Gaeseb, Johannes

Publication type:

Article

Computational study of some potential inhibitors of COVID-19: A DFT analysis.

Published in:

Quantitative Biology, 2022, v. 10, n. 4, p. 341, doi. 10.15302/J-QB-022-0287

By:

Ranjan, Prabhat;
Gaurav, Kumar;
Chakraborty, Tanmoy

Publication type:

Article

Renal Safety of Tenofovir Alafenamide versus Tenofovir Disoproxil Fumarate for the Treatment of Chronic Hepatitis B Patients: An Evidence-based Case Report.

Published in:

Indonesian Journal of Gastroenterology, Hepatology & Digestive Endoscopy, 2024, v. 25, n. 2, p. 271, doi. 10.24871/2522024368

By:

Sandi Lesmana Dewi, Putu Itta;
Narapati Pamungkas, Kadek Mercu;
Mariadi, I. Ketut

Publication type:

Article

Evaluation Effect of Tenofovir Alafenamide (TAF) in Long-Term Therapy for Chronic Hepatitis B: A Systematic Review.

Published in:

Indonesian Journal of Gastroenterology, Hepatology & Digestive Endoscopy, 2022, v. 23, n. 3, p. 216, doi. 10.24871/2332022217-226

By:

Saputra, Rada Citra;
Hidayat, Nur

Publication type:

Article

Tenofovir Alafenamide (TAF) as Long-Term Therapy for Chronic Hepatitis B: Is It the Best Choice?

Published in:

Indonesian Journal of Gastroenterology, Hepatology & Digestive Endoscopy, 2022, v. 23, n. 3, p. 173, doi. 10.24871/2332022173

By:

Hasan, Irsan

Publication type:

Article

General and bone pain syndrome in a patient treated with tenofovir.

Published in:

Journal of Osteoporosis & Mineral Metabolism / Revista de Osteoporosis y Metabolismo Mineral (English edition), 2015, v. 7, n. 4, p. 112, doi. 10.4321/s1889-836x2015000400006

By:

Arnaiz de las Revillas, F.;
Marcote Ibáñez, C.;
González-Lamuño, D.;
García Unzueta, M.;
Lino Montenegro, E.;
Riancho, J. A.

Publication type:

Article

Bictegravir Plus Tenofovir Alafenamide Nanoformulation as a Long-Acting Pre-Exposure Prophylaxis Regimen: Application of Modeling to Design Non-Human Primate Pharmacokinetic Experiments.

Published in:

Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.603242

By:

Perazzolo, Simone;
Mandal, Subhra;
Prathipati, Pavan K.;
Destache, Christopher J.

Publication type:

Article

Multispecies Evaluation of a Long-Acting Tenofovir Alafenamide Subdermal Implant for HIV Prophylaxis.

Published in:

Frontiers in Pharmacology, 2020, v. 11`, p. N.PAG, doi. 10.3389/fphar.2020.569373

By:

Gunawardana, Manjula;
Remedios-Chan, Mariana;
Sanchez, Debbie;
Webster, Simon;
Galvan, Patricia;
Fanter, Rob;
Castonguay, Amalia E.;
Webster, Paul;
Moss, John A.;
Kuo, Joseph;
Gallay, Philippe A.;
Vincent, Kathleen L.;
Motamedi, Massoud;
Weinberger, Dana;
Marzinke, Mark A.;
Hendrix, Craig W.;
Baum, Marc M.

Publication type:

Article

Urine Assay to Measure Tenofovir Concentrations in Patients Taking Tenofovir Alafenamide.

Published in:

Frontiers in Pharmacology, 2020, v. 11, p. 1, doi. 10.3389/fphar.2020.00286

By:

Lalley-Chareczko, Linden;
Hiserodt, Emily;
Moorthy, Ganesh;
Zuppa, Athena;
Mounzer, Karam;
Koenig, Helen

Publication type:

Article

Proximal tubular dysfunction and kidney injury associated with tenofovir in HIV patients: a case series.

Published in:

Clinical Kidney Journal, 2015, v. 8, n. 4, p. 420, doi. 10.1093/ckj/sfv041

By:

Waheed, Sana;
Attia, Doaa;
Estrella, Michelle M.;
Zafar, Yousuf;
Atta, Mohamed G.;
Lucas, Gregory M.;
Fine, Derek M.

Publication type:

Article

Clinical outcomes of a combined HIV and renal clinic.

Published in:

Clinical Kidney Journal, 2012, v. 5, n. 6, p. 530, doi. 10.1093/ckj/sfs141

By:

McClure, Mark;
Singh, G. Jagjit;
Rayment, Michael;
Jones, Rachael;
Levy, Jeremy B.

Publication type:

Article

Promoting Antiviral Access and Adherence in the Expansion of Hepatitis B Prevention Programs: Insights From the Democratic Republic of Congo.

Published in:

Journal of the Pediatric Infectious Diseases Society, 2024, v. 13, p. S148, doi. 10.1093/jpids/piae081

By:

Thahir, Sahal;
Morgan, Camille E;
Ngimbi, Patrick;
Kashamuka, Melchior Mwandagalirwa;
Ntambua, Sarah;
Matondo, Jolie;
Tabala, Martine;
Mbendi, Charles;
Kaba, Didine;
Yotebieng, Marcel;
Parr, Jonathan B;
Banek, Kristin;
Thompson, Peyton

Publication type:

Article

Population Pharmacokinetics of Dolutegravir in African Children: Results From the CHAPAS-4 Trial.

Published in:

Journal of the Pediatric Infectious Diseases Society, 2024, v. 13, n. 9, p. 496, doi. 10.1093/jpids/piae076

By:

Waalewijn, Hylke;
Wasmann, Roeland E;
Bamford, Alasdair;
Gibb, Diana M;
McIlleron, Helen M;
Colbers, Angela;
Burger, David M;
Denti, Paolo;
team, the CHAPAS-4 trial

Publication type:

Article

Phosphaturia in HIV-Exposed Uninfected Neonates Associated with Maternal Use of Tenofovir Disoproxil Fumarate in Late Pregnancy.

Published in:

Journal of the Pediatric Infectious Diseases Society, 2024, v. 13, n. 8, p. 396, doi. 10.1093/jpids/piae054

By:

Purswani, Murli U;
Jacobson, Denise L;
DiMeglio, Linda A;
Yao, Tzy-Jyun;
Kopp, Jeffrey B;
Dyke, Russell B Van;
Yu, Wendy;
Siberry, George K;
(PHACS), For the Pediatric HIV/AIDS Cohort Study

Publication type:

Article

Efficacy, Safety, and Tolerability of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living With HIV: Results Through Week 96 from IMPAACT 2014.

Published in:

Journal of the Pediatric Infectious Diseases Society, 2023, v. 12, n. 12, p. 602, doi. 10.1093/jpids/piad078

By:

Rungmaitree, Supattra;
Aurpibul, Linda;
Best, Brookie M;
Li, Xiang;
Warshaw, Meredith G;
Wan, Hong;
Tobin, Nicole H;
Jumes, Patricia;
Leavitt, Randi;
McCarthy, Katie;
Scheckter, Rachel;
Ounchanum, Pradthana;
Violari, Avy;
Teppler, Hedy;
Campbell, Havilland;
Krotje, Chelsea;
Townley, Ellen;
Moye, Jack;
Melvin, Ann J;
team, IMPAACT 2014 study

Publication type:

Article

Phototoxicity free quantum dot-based niosome formulation for controlled drug release and its monitoring.

Published in:

Applied Nanoscience, 2018, v. 8, n. 4, p. 617, doi. 10.1007/s13204-018-0757-1

By:

Kumar, Sunil;
Kang, T. W.;
Bala, Suman;
Kamboj, Sunil;
Jeon, H. C.

Publication type:

Article

Efficacy of long-term tenofovir-based rescue therapy in patients with chronic hepatitis B refractory to nucleoside/nucleotide analogs.

Published in:

2017

By:

Suzuki, Fumitaka;
Suzuki, Yoshiyuki;
Hosaka, Tetsuya;
Sezaki, Hitomi;
Akuta, Norio;
Fujiyama, Shunichiro;
Kawamura, Yusuke;
Kobayashi, Masahiro;
Saitoh, Satoshi;
Arase, Yasuji;
Ikeda, Kenji;
Kobayashi, Mariko;
Mineta, Rie;
Suzuki, Yukiko;
Kumada, Hiromitsu

Publication type:

journal article

Drug Use Evaluation of Tenofovir/Lamivudine/Dolutegravir (TLD) Fixed-Dose Combination for Initiation and Transition Among HIV-Infected Individuals Attending Lumame Primary Hospital, North West Ethiopia.

Published in:

Integrated Pharmacy Research & Practice, 2024, v. 13, p. 31, doi. 10.2147/IPRP.S455351

By:

Tegegne, Bantayehu Addis;
Alehegn, Agumas Alemu;
Kassahun, Mengistie

Publication type:

Article

Tenofovir for treatment of hepatitis B virus reactivation in patients with chronic GVHD.

Published in:

2011

By:

Hilgendorf, I.;
Loebermann, M.;
Borchert, K.;
Junghanss, C.;
Freund, M.;
Schmitt, M.

Publication type:

Letter